Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

News
Jun 2026
Ben Katzenellenbogen Discusses Deckers v. Quince UGG Design Patent Trial with Legal and Fashion Industry Media
In interviews with World Trademark Review, MLex, and Women’s Wear Daily, Knobbe Martens partner Ben Katzenellenbogen shared his insights on a recent California district court decision in a design patent...
Newsletter
Jun 2026
PTAB Update | May 2026
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board Ted M. Cannon In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc.,...
Blog - Litigation
Jun 2026
When ‘Any Patent’ Means No Patent: Federal Circuit Reverses Non-Specific Verdict
OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen, Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary: A verdict form...